Our Nature publication released in July 2015 “Lanosterol reverses protein aggregation in cataracts” may be accessed here.
While we are excited about the positive outcome and are currently continuing testing on existing animal models while preparing for our next steps in the research and development process – due to strict drug testing regulations, the process of approving a drug for human or animal use after successful animal trials is extremely lengthy and we do not recommend patients with cataracts to await drug approval at such an early stage of testing. Due to this reason, we are neither accepting test subjects nor distributing treatments as of this moment. Please consult your ophthalmologist and veterinarian for the recommended next steps in treatment. Thank you again for your interest!
Feel free to check back periodically for any updates on the drug development process. To leave your information for future contact, please fill out our contact request form.